Covidien PLC (COV)

106.71
1.36 1.26
Prev Close 108.07
Open 107.97
Day Low/High 106.71 / 108.16
52 Wk Low/High 65.97 / 108.57
Volume 24.76M
Avg Volume 3.84M
Exchange
Shares Outstanding 454.51M
Market Cap 48.50B
EPS 3.68
Div & Yield 1.44 (1.30%)

Latest News

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF) an advanced medical technologies company, has scheduled a conference call for Tuesday May 29 th 2018 at 9:00 am ET.

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been informed that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100...

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the...

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be featuring its perioperative suite of innovative products including...

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its MediClear™ PreOp has received Frost & Sullivan's 2018 North American...

Covalon Announces Its Participation In Medical Japan 2018

Covalon Announces Its Participation In Medical Japan 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be participating in the Ontario Government's Life Sciences Trade...

Covalon Announces Strong First Quarter Financial Results

Covalon Announces Strong First Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Further to its press release dated October 27, 2017, Covalon Technologies Ltd.

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is extremely pleased to announce that Major General (Ret.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the issuance of 60,000 stock options to financial advisors of the Company.

Covalon Announces Major Milestone: FDA Clearance For MediClear™ PreOp

Covalon Announces Major Milestone: FDA Clearance For MediClear™ PreOp

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today it has received United States Food and Drug Administration ("FDA") clearance to...

Covalon Announces The Commencement Of Trading On The OTCQX Market In The United States

Covalon Announces The Commencement Of Trading On The OTCQX Market In The United States

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that shares of the Company have commenced trading on the OTCQX® Best...

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named...

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

Today Covidien (COV) Hits New Lifetime High

Today Covidien (COV) Hits New Lifetime High

Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien is sponsoring the Retreat & Refresh Stroke Camp (Stroke Camp), a three-day retreat for stroke survivors, caregivers and family members dedicated to helping these often forgotten victims of stroke relax...

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) shares are climbing after the company reported its first quarter earnings results.

Covidien Reports First-Quarter 2015 Results

Covidien Reports First-Quarter 2015 Results

Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2015.

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

Shares of Covidien (COV) closed higher Wednesday ahead of the healthcare company's first-quarter earnings report before the market open Thursday.

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 21, 2015

Announcement Under Irish Takeover Rules Relevant Securities In Issue - January 21, 2015

In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the " Company") confirms that, as of the close of business on January 20, 2015, the Company's issued share capital, excluding treasury...

Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings

Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings

Johnson & Johnson's handsome dividend yield and projected 5.5% annual growth rate for the next five years makes it a solid investment.

Covidien Plc To Report First-Quarter Fiscal 2015 Results On January 22, 2015

Covidien Plc To Report First-Quarter Fiscal 2015 Results On January 22, 2015

Covidien plc (NYSE: COV) will report first-quarter fiscal 2015 results on January 22.